Determinants of pain interference and headache impact in patients who have chronic migraine with medication overuse: Results from the MOTS trial
Objective “Pain interference” and “headache impact” refer to negative consequences that pain and headache have on one’s life. This study investigated determinants of these negative impacts in a large patient cohort who have chronic migraine with medication overuse. Methods Six hundred and eleven adu...
Gespeichert in:
| Veröffentlicht in: | Cephalalgia 2021-09, Vol.41 (10), p.1053-1064 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1064 |
|---|---|
| container_issue | 10 |
| container_start_page | 1053 |
| container_title | Cephalalgia |
| container_volume | 41 |
| creator | Schwedt, Todd J Sahai-Srivastava, Soma Murinova, Natalia Birlea, Marius Ahmed, Zubair Digre, Kathleen Lopez, Kristina Mullally, William Blaya, Maike Tiede Pippitt, Karly Cutrer, Fred Michael DeLange, Justin Schecht, Howard Rizzoli, Paul Lane, Judy Wald, John Cortez, Melissa M Martin, Vincent T Spare, Nicole M Hentz, Joseph G Robert, Teri Dodick, David W |
| description | Objective
“Pain interference” and “headache impact” refer to negative consequences that pain and headache have on one’s life. This study investigated determinants of these negative impacts in a large patient cohort who have chronic migraine with medication overuse.
Methods
Six hundred and eleven adults were enrolled from 34 headache, neurology, and primary care clinics. Negative consequences of chronic migraine with medication overuse were determined using the Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference 6b questionnaire and the Headache Impact Test 6. Relationships between PROMIS-6b and Headache Impact Test 6 scores with demographics, headache characteristics, medication use, anxiety symptoms, and depression symptoms were assessed with linear regression. Elastic Net regression was used to develop a multiple regression model.
Results
PROMIS-6b T-Scores averaged 65.2 (SD 5.4) and Headache Impact Test 6 scores averaged 65.0 (SD 5.3), indicating severe negative consequences of chronic migraine with medication overuse. Chronic migraine with medication overuse interfered with enjoyment of life, concentration, daily activities, doing tasks away from home, and socializing. Depression symptom severity had the strongest relationship with pain interference and headache impact. Moderate-to-severe headache frequency, headache intensity, and anxiety symptoms were also associated with pain interference and headache impact.
Conclusions
Chronic migraine with medication overuse is associated with substantial negative consequences, the extent of which is most strongly related to depression symptoms. |
| doi_str_mv | 10.1177/03331024211006903 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_AFRWT</sourceid><recordid>TN_cdi_proquest_miscellaneous_2521493957</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_03331024211006903</sage_id><sourcerecordid>2521493957</sourcerecordid><originalsourceid>FETCH-LOGICAL-c340t-eebcf7a32ab003075947b412d4f4a9165167b1a0e131116cf3cec22ca19a76373</originalsourceid><addsrcrecordid>eNp9kc9u1DAQhy0EokvhAbggH7mkeGwnWXNDLf-kokptOUcT76RxldiL7bTiLfrIONrCBamnkWa-3yfNDGNvQZwAtO0HoZQCIbUEEKIxQj1jG9DNtpJmK5-zzTqvVuCIvUrpVghRN6J5yY6UMmortdmwhzPKFGfn0efEw8D36Dx3vjQHiuQtcfQ7PhLu0I7E3bxHmwtQwOxoDd2PgY94R9yOMXhn-exuYrEQv3d55DPtnC1s8DzcUVwSfeSXlJapRIcYZp6L9sfF9RXP0eH0mr0YcEr05rEes59fPl-ffqvOL75-P_10XlmlRa6Ieju0qCT2QijR1ka3vQa504NGA00NTdsDCgIFAI0dlCUrpUUw2DaqVcfs_cG7j-HXQil3s0uWpgk9hSV1spagjTL1isIBtTGkFGno9tHNGH93ILr1Ed1_jyiZd4_6pS8X-Jf4e_kCnByAhDfU3YYl-rLuE8Y_44GRsg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2521493957</pqid></control><display><type>article</type><title>Determinants of pain interference and headache impact in patients who have chronic migraine with medication overuse: Results from the MOTS trial</title><source>Sage Journals GOLD Open Access 2024</source><creator>Schwedt, Todd J ; Sahai-Srivastava, Soma ; Murinova, Natalia ; Birlea, Marius ; Ahmed, Zubair ; Digre, Kathleen ; Lopez, Kristina ; Mullally, William ; Blaya, Maike Tiede ; Pippitt, Karly ; Cutrer, Fred Michael ; DeLange, Justin ; Schecht, Howard ; Rizzoli, Paul ; Lane, Judy ; Wald, John ; Cortez, Melissa M ; Martin, Vincent T ; Spare, Nicole M ; Hentz, Joseph G ; Robert, Teri ; Dodick, David W</creator><creatorcontrib>Schwedt, Todd J ; Sahai-Srivastava, Soma ; Murinova, Natalia ; Birlea, Marius ; Ahmed, Zubair ; Digre, Kathleen ; Lopez, Kristina ; Mullally, William ; Blaya, Maike Tiede ; Pippitt, Karly ; Cutrer, Fred Michael ; DeLange, Justin ; Schecht, Howard ; Rizzoli, Paul ; Lane, Judy ; Wald, John ; Cortez, Melissa M ; Martin, Vincent T ; Spare, Nicole M ; Hentz, Joseph G ; Robert, Teri ; Dodick, David W ; MOTS Investigators ; on behalf of the MOTS Investigators</creatorcontrib><description>Objective
“Pain interference” and “headache impact” refer to negative consequences that pain and headache have on one’s life. This study investigated determinants of these negative impacts in a large patient cohort who have chronic migraine with medication overuse.
Methods
Six hundred and eleven adults were enrolled from 34 headache, neurology, and primary care clinics. Negative consequences of chronic migraine with medication overuse were determined using the Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference 6b questionnaire and the Headache Impact Test 6. Relationships between PROMIS-6b and Headache Impact Test 6 scores with demographics, headache characteristics, medication use, anxiety symptoms, and depression symptoms were assessed with linear regression. Elastic Net regression was used to develop a multiple regression model.
Results
PROMIS-6b T-Scores averaged 65.2 (SD 5.4) and Headache Impact Test 6 scores averaged 65.0 (SD 5.3), indicating severe negative consequences of chronic migraine with medication overuse. Chronic migraine with medication overuse interfered with enjoyment of life, concentration, daily activities, doing tasks away from home, and socializing. Depression symptom severity had the strongest relationship with pain interference and headache impact. Moderate-to-severe headache frequency, headache intensity, and anxiety symptoms were also associated with pain interference and headache impact.
Conclusions
Chronic migraine with medication overuse is associated with substantial negative consequences, the extent of which is most strongly related to depression symptoms.</description><identifier>ISSN: 0333-1024</identifier><identifier>EISSN: 1468-2982</identifier><identifier>DOI: 10.1177/03331024211006903</identifier><identifier>PMID: 33938249</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><ispartof>Cephalalgia, 2021-09, Vol.41 (10), p.1053-1064</ispartof><rights>International Headache Society 2021</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c340t-eebcf7a32ab003075947b412d4f4a9165167b1a0e131116cf3cec22ca19a76373</citedby><cites>FETCH-LOGICAL-c340t-eebcf7a32ab003075947b412d4f4a9165167b1a0e131116cf3cec22ca19a76373</cites><orcidid>0000-0002-0596-5907</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/03331024211006903$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/03331024211006903$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,778,782,21949,27836,27907,27908,44928,45316</link.rule.ids><linktorsrc>$$Uhttps://journals.sagepub.com/doi/full/10.1177/03331024211006903?utm_source=summon&utm_medium=discovery-provider$$EView_record_in_SAGE_Publications$$FView_record_in_$$GSAGE_Publications</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33938249$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schwedt, Todd J</creatorcontrib><creatorcontrib>Sahai-Srivastava, Soma</creatorcontrib><creatorcontrib>Murinova, Natalia</creatorcontrib><creatorcontrib>Birlea, Marius</creatorcontrib><creatorcontrib>Ahmed, Zubair</creatorcontrib><creatorcontrib>Digre, Kathleen</creatorcontrib><creatorcontrib>Lopez, Kristina</creatorcontrib><creatorcontrib>Mullally, William</creatorcontrib><creatorcontrib>Blaya, Maike Tiede</creatorcontrib><creatorcontrib>Pippitt, Karly</creatorcontrib><creatorcontrib>Cutrer, Fred Michael</creatorcontrib><creatorcontrib>DeLange, Justin</creatorcontrib><creatorcontrib>Schecht, Howard</creatorcontrib><creatorcontrib>Rizzoli, Paul</creatorcontrib><creatorcontrib>Lane, Judy</creatorcontrib><creatorcontrib>Wald, John</creatorcontrib><creatorcontrib>Cortez, Melissa M</creatorcontrib><creatorcontrib>Martin, Vincent T</creatorcontrib><creatorcontrib>Spare, Nicole M</creatorcontrib><creatorcontrib>Hentz, Joseph G</creatorcontrib><creatorcontrib>Robert, Teri</creatorcontrib><creatorcontrib>Dodick, David W</creatorcontrib><creatorcontrib>MOTS Investigators</creatorcontrib><creatorcontrib>on behalf of the MOTS Investigators</creatorcontrib><title>Determinants of pain interference and headache impact in patients who have chronic migraine with medication overuse: Results from the MOTS trial</title><title>Cephalalgia</title><addtitle>Cephalalgia</addtitle><description>Objective
“Pain interference” and “headache impact” refer to negative consequences that pain and headache have on one’s life. This study investigated determinants of these negative impacts in a large patient cohort who have chronic migraine with medication overuse.
Methods
Six hundred and eleven adults were enrolled from 34 headache, neurology, and primary care clinics. Negative consequences of chronic migraine with medication overuse were determined using the Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference 6b questionnaire and the Headache Impact Test 6. Relationships between PROMIS-6b and Headache Impact Test 6 scores with demographics, headache characteristics, medication use, anxiety symptoms, and depression symptoms were assessed with linear regression. Elastic Net regression was used to develop a multiple regression model.
Results
PROMIS-6b T-Scores averaged 65.2 (SD 5.4) and Headache Impact Test 6 scores averaged 65.0 (SD 5.3), indicating severe negative consequences of chronic migraine with medication overuse. Chronic migraine with medication overuse interfered with enjoyment of life, concentration, daily activities, doing tasks away from home, and socializing. Depression symptom severity had the strongest relationship with pain interference and headache impact. Moderate-to-severe headache frequency, headache intensity, and anxiety symptoms were also associated with pain interference and headache impact.
Conclusions
Chronic migraine with medication overuse is associated with substantial negative consequences, the extent of which is most strongly related to depression symptoms.</description><issn>0333-1024</issn><issn>1468-2982</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kc9u1DAQhy0EokvhAbggH7mkeGwnWXNDLf-kokptOUcT76RxldiL7bTiLfrIONrCBamnkWa-3yfNDGNvQZwAtO0HoZQCIbUEEKIxQj1jG9DNtpJmK5-zzTqvVuCIvUrpVghRN6J5yY6UMmortdmwhzPKFGfn0efEw8D36Dx3vjQHiuQtcfQ7PhLu0I7E3bxHmwtQwOxoDd2PgY94R9yOMXhn-exuYrEQv3d55DPtnC1s8DzcUVwSfeSXlJapRIcYZp6L9sfF9RXP0eH0mr0YcEr05rEes59fPl-ffqvOL75-P_10XlmlRa6Ieju0qCT2QijR1ka3vQa504NGA00NTdsDCgIFAI0dlCUrpUUw2DaqVcfs_cG7j-HXQil3s0uWpgk9hSV1spagjTL1isIBtTGkFGno9tHNGH93ILr1Ed1_jyiZd4_6pS8X-Jf4e_kCnByAhDfU3YYl-rLuE8Y_44GRsg</recordid><startdate>20210901</startdate><enddate>20210901</enddate><creator>Schwedt, Todd J</creator><creator>Sahai-Srivastava, Soma</creator><creator>Murinova, Natalia</creator><creator>Birlea, Marius</creator><creator>Ahmed, Zubair</creator><creator>Digre, Kathleen</creator><creator>Lopez, Kristina</creator><creator>Mullally, William</creator><creator>Blaya, Maike Tiede</creator><creator>Pippitt, Karly</creator><creator>Cutrer, Fred Michael</creator><creator>DeLange, Justin</creator><creator>Schecht, Howard</creator><creator>Rizzoli, Paul</creator><creator>Lane, Judy</creator><creator>Wald, John</creator><creator>Cortez, Melissa M</creator><creator>Martin, Vincent T</creator><creator>Spare, Nicole M</creator><creator>Hentz, Joseph G</creator><creator>Robert, Teri</creator><creator>Dodick, David W</creator><general>SAGE Publications</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0596-5907</orcidid></search><sort><creationdate>20210901</creationdate><title>Determinants of pain interference and headache impact in patients who have chronic migraine with medication overuse: Results from the MOTS trial</title><author>Schwedt, Todd J ; Sahai-Srivastava, Soma ; Murinova, Natalia ; Birlea, Marius ; Ahmed, Zubair ; Digre, Kathleen ; Lopez, Kristina ; Mullally, William ; Blaya, Maike Tiede ; Pippitt, Karly ; Cutrer, Fred Michael ; DeLange, Justin ; Schecht, Howard ; Rizzoli, Paul ; Lane, Judy ; Wald, John ; Cortez, Melissa M ; Martin, Vincent T ; Spare, Nicole M ; Hentz, Joseph G ; Robert, Teri ; Dodick, David W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c340t-eebcf7a32ab003075947b412d4f4a9165167b1a0e131116cf3cec22ca19a76373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schwedt, Todd J</creatorcontrib><creatorcontrib>Sahai-Srivastava, Soma</creatorcontrib><creatorcontrib>Murinova, Natalia</creatorcontrib><creatorcontrib>Birlea, Marius</creatorcontrib><creatorcontrib>Ahmed, Zubair</creatorcontrib><creatorcontrib>Digre, Kathleen</creatorcontrib><creatorcontrib>Lopez, Kristina</creatorcontrib><creatorcontrib>Mullally, William</creatorcontrib><creatorcontrib>Blaya, Maike Tiede</creatorcontrib><creatorcontrib>Pippitt, Karly</creatorcontrib><creatorcontrib>Cutrer, Fred Michael</creatorcontrib><creatorcontrib>DeLange, Justin</creatorcontrib><creatorcontrib>Schecht, Howard</creatorcontrib><creatorcontrib>Rizzoli, Paul</creatorcontrib><creatorcontrib>Lane, Judy</creatorcontrib><creatorcontrib>Wald, John</creatorcontrib><creatorcontrib>Cortez, Melissa M</creatorcontrib><creatorcontrib>Martin, Vincent T</creatorcontrib><creatorcontrib>Spare, Nicole M</creatorcontrib><creatorcontrib>Hentz, Joseph G</creatorcontrib><creatorcontrib>Robert, Teri</creatorcontrib><creatorcontrib>Dodick, David W</creatorcontrib><creatorcontrib>MOTS Investigators</creatorcontrib><creatorcontrib>on behalf of the MOTS Investigators</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cephalalgia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Schwedt, Todd J</au><au>Sahai-Srivastava, Soma</au><au>Murinova, Natalia</au><au>Birlea, Marius</au><au>Ahmed, Zubair</au><au>Digre, Kathleen</au><au>Lopez, Kristina</au><au>Mullally, William</au><au>Blaya, Maike Tiede</au><au>Pippitt, Karly</au><au>Cutrer, Fred Michael</au><au>DeLange, Justin</au><au>Schecht, Howard</au><au>Rizzoli, Paul</au><au>Lane, Judy</au><au>Wald, John</au><au>Cortez, Melissa M</au><au>Martin, Vincent T</au><au>Spare, Nicole M</au><au>Hentz, Joseph G</au><au>Robert, Teri</au><au>Dodick, David W</au><aucorp>MOTS Investigators</aucorp><aucorp>on behalf of the MOTS Investigators</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Determinants of pain interference and headache impact in patients who have chronic migraine with medication overuse: Results from the MOTS trial</atitle><jtitle>Cephalalgia</jtitle><addtitle>Cephalalgia</addtitle><date>2021-09-01</date><risdate>2021</risdate><volume>41</volume><issue>10</issue><spage>1053</spage><epage>1064</epage><pages>1053-1064</pages><issn>0333-1024</issn><eissn>1468-2982</eissn><abstract>Objective
“Pain interference” and “headache impact” refer to negative consequences that pain and headache have on one’s life. This study investigated determinants of these negative impacts in a large patient cohort who have chronic migraine with medication overuse.
Methods
Six hundred and eleven adults were enrolled from 34 headache, neurology, and primary care clinics. Negative consequences of chronic migraine with medication overuse were determined using the Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference 6b questionnaire and the Headache Impact Test 6. Relationships between PROMIS-6b and Headache Impact Test 6 scores with demographics, headache characteristics, medication use, anxiety symptoms, and depression symptoms were assessed with linear regression. Elastic Net regression was used to develop a multiple regression model.
Results
PROMIS-6b T-Scores averaged 65.2 (SD 5.4) and Headache Impact Test 6 scores averaged 65.0 (SD 5.3), indicating severe negative consequences of chronic migraine with medication overuse. Chronic migraine with medication overuse interfered with enjoyment of life, concentration, daily activities, doing tasks away from home, and socializing. Depression symptom severity had the strongest relationship with pain interference and headache impact. Moderate-to-severe headache frequency, headache intensity, and anxiety symptoms were also associated with pain interference and headache impact.
Conclusions
Chronic migraine with medication overuse is associated with substantial negative consequences, the extent of which is most strongly related to depression symptoms.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>33938249</pmid><doi>10.1177/03331024211006903</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-0596-5907</orcidid></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | ISSN: 0333-1024 |
| ispartof | Cephalalgia, 2021-09, Vol.41 (10), p.1053-1064 |
| issn | 0333-1024 1468-2982 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2521493957 |
| source | Sage Journals GOLD Open Access 2024 |
| title | Determinants of pain interference and headache impact in patients who have chronic migraine with medication overuse: Results from the MOTS trial |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T15%3A47%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_AFRWT&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Determinants%20of%20pain%20interference%20and%20headache%20impact%20in%20patients%20who%20have%20chronic%20migraine%20with%20medication%20overuse:%20Results%20from%20the%20MOTS%20trial&rft.jtitle=Cephalalgia&rft.au=Schwedt,%20Todd%20J&rft.aucorp=MOTS%20Investigators&rft.date=2021-09-01&rft.volume=41&rft.issue=10&rft.spage=1053&rft.epage=1064&rft.pages=1053-1064&rft.issn=0333-1024&rft.eissn=1468-2982&rft_id=info:doi/10.1177/03331024211006903&rft_dat=%3Cproquest_AFRWT%3E2521493957%3C/proquest_AFRWT%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2521493957&rft_id=info:pmid/33938249&rft_sage_id=10.1177_03331024211006903&rfr_iscdi=true |